Medicare Enrolled

Dr. Glenn Ehresmann, M.D.

Rheumatology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1520 SAN PABLO ST, Los Angeles, CA 90033
3234425100
In practice since 2006 (19 years)
NPI: 1043248727 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ehresmann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ehresmann? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ehresmann

Dr. Glenn Ehresmann is a rheumatology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ehresmann performed 468 Medicare services across 286 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ehresmann received a total of $616,108 from 27 pharmaceutical and/or device companies across 1020 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ehresmann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 468 Medicare services $616,108 industry payments

Medicare Practice Summary

Medicare Utilization ↗
468
Medicare services
Bottom 37% in CA for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
286
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
278 $75 $400
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
87 $42 $460
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
48 $25 $340
Tendon or ligament injection
A procedure involving the injection of medication into a tendon or ligament.
24 $29 $180
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
18 $56 $275
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $49 $275
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$616,108
Total received (2018-2024)
Avg $88,015/year across 7 years
Top 2% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
1,020
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$596,751 (96.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,815 (2.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,542 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$36,149
2023
$34,456
2022
$50,136
2021
$35,601
2020
$64,083
2019
$209,605
2018
$186,078

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$19,145
Amgen Inc.
$9,504
ABBVIE INC.
$6,462
Janssen Biotech, Inc.
$239
GENZYME CORPORATION
$236
GlaxoSmithKline, LLC.
$208
Novartis Pharmaceuticals Corporation
$150
PFIZER INC.
$87
Aurinia Pharma U.S., Inc.
$59
Alexion Pharmaceuticals, Inc.
$37
Genentech USA, Inc.
$20
Top 3 companies account for 97.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$108,210
Lilly USA, LLC
$77,266
Janssen Scientific Affairs, LLC
$74,148
Mallinckrodt Hospital Products Inc.
$63,962
Genentech USA, Inc.
$54,858
Celgene Corporation
$44,418
ABBVIE INC.
$37,427
Mallinckrodt Enterprises LLC
$37,165
PFIZER INC.
$26,429
GENZYME CORPORATION
$25,335
AbbVie, Inc.
$23,422
AbbVie Inc.
$20,912
Ironwood Pharmaceuticals, Inc
$5,779
Gilead Sciences, Inc.
$5,036
Regeneron Healthcare Solutions, Inc.
$3,858
Janssen Biotech, Inc.
$3,520
GlaxoSmithKline, LLC.
$2,226
Aurinia Pharma U.S., Inc.
$752
SANOFI-AVENTIS U.S. LLC
$417
UCB, Inc.
$287
Novartis Pharmaceuticals Corporation
$259
Novo Nordisk Inc
$133
AstraZeneca Pharmaceuticals LP
$109
Mallinckrodt LLC
$76
Radius Health, Inc.
$46
Alexion Pharmaceuticals, Inc.
$37
Kiniksa Pharmaceuticals, Ltd.
$22
Top 3 companies account for 42.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · CELLEX/XTS PHOTOPHERESIS SYSTEM · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · Cimzia · DUZALLO · EVENITY · Enbrel · HUMIRA · Humira · KEVZARA · LUPKYNIS · LYRICA · NO PRODUCT DISCUSSED · NUCALA · OLUMIANT · Otezla · Prolia · RINVOQ · Rinvoq · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tremfya · Tymlos · ULTOMIRIS · UVADEX · Wegovy · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for rheumatology in CA.

Looking for a rheumatology specialist in Los Angeles?
Compare rheumatologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
214
Per 100K population
2.2
County median income
$87,760
Nearest hospital
ADVENTIST HEALTH WHITE MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ehresmann is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ehresmann experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ehresmann performed 278 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ehresmann receive payments from pharmaceutical companies?
Yes. Dr. Ehresmann received a total of $616,108 from 27 companies across 1,020 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ehresmann's costs compare to other rheumatologists in Los Angeles?
Dr. Ehresmann's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ehresmann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →